• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies.妇科恶性肿瘤盆腔脏器清除术的医院手术量与围手术期死亡率
J Surg Oncol. 2020 Feb;121(2):402-409. doi: 10.1002/jso.25770. Epub 2019 Nov 19.
2
Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States.医院手术量与宫颈癌保留生育功能的根治性宫颈切除术围手术期结局的关联:美国的一项全国性研究。
Gynecol Oncol. 2020 Apr;157(1):173-180. doi: 10.1016/j.ygyno.2020.01.015. Epub 2020 Jan 22.
3
Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.盆腔廓清术治疗妇科恶性肿瘤的疗效和结局:一项基于人群的研究。
Gynecol Oncol. 2019 May;153(2):368-375. doi: 10.1016/j.ygyno.2019.02.002. Epub 2019 Feb 19.
4
Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.妇科恶性肿瘤微创骨盆切除术的利用和围手术期结果:美国的一项全国性研究。
Gynecol Oncol. 2021 Apr;161(1):39-45. doi: 10.1016/j.ygyno.2020.12.036. Epub 2021 Jan 3.
5
Influence of tumor size on outcomes following pelvic exenteration.肿瘤大小对盆腔廓清术后结局的影响。
Gynecol Oncol. 2017 Nov;147(2):345-350. doi: 10.1016/j.ygyno.2017.08.014. Epub 2017 Aug 16.
6
Risk factors for major complications following pelvic exenteration: A NSQIP study.盆腔廓清术后主要并发症的风险因素:一项 NSQIP 研究。
Eur J Surg Oncol. 2024 Dec;50(12):108761. doi: 10.1016/j.ejso.2024.108761. Epub 2024 Oct 13.
7
Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.微创盆腔廓清术治疗妇科恶性肿瘤:多机构病例系列及文献复习。
J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1316-1326. doi: 10.1016/j.jmig.2018.12.019. Epub 2019 Jan 4.
8
Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.妇科恶性肿瘤盆腔廓清术后尿流改道的主要并发症:124例患者23年单中心经验
Gynecol Oncol. 2004 Feb;92(2):680-3. doi: 10.1016/j.ygyno.2003.11.003.
9
Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.微创与开放盆腔廓清术治疗直肠癌:围手术期和 3 年肿瘤学结局的比较分析。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab074.
10
The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.外科医生手术量对妇科癌症盆腔廓清术后结局的影响。
J Gynecol Oncol. 2018 Sep;29(5):e68. doi: 10.3802/jgo.2018.29.e68. Epub 2018 May 4.

引用本文的文献

1
Intraoperative Radiation Therapy (IORT) in Gynecologic Cancers: A Scoping Review.妇科癌症的术中放射治疗(IORT):一项范围综述
Cancers (Basel). 2025 Apr 18;17(8):1356. doi: 10.3390/cancers17081356.
2
Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.妇科恶性肿瘤盆腔廓清术的长期结果:单中心回顾性队列研究。
BMC Cancer. 2024 Jan 17;24(1):88. doi: 10.1186/s12885-024-11836-3.
3
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis.医院病例数量对子宫肉瘤预后的影响:SARCUT研究亚组分析
Ann Surg Oncol. 2023 Nov;30(12):7645-7652. doi: 10.1245/s10434-023-13826-4. Epub 2023 Jul 17.
4
ASO Author Reflections: Low Case-Load and Lack of Centralization have Negative Impact on Uterine Sarcoma Outcomes.ASO作者反思:低病例数和缺乏集中化对子宫肉瘤的治疗结果有负面影响。
Ann Surg Oncol. 2023 Nov;30(12):7663-7664. doi: 10.1245/s10434-023-13871-z. Epub 2023 Jul 15.
5
The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study.外科医生手术量对激光汽化术结果的影响:单中心回顾性研究。
Curr Oncol. 2022 May 23;29(5):3770-3779. doi: 10.3390/curroncol29050302.
6
Regional variance in treatment and outcomes of locally invasive (T4) rectal cancer in Australia and New Zealand: analysis of the Bi-National Colorectal Cancer Audit.澳大利亚和新西兰局部侵袭性(T4)直肠癌治疗和结局的地域差异:双国家结直肠癌审计分析。
ANZ J Surg. 2022 Jul;92(7-8):1772-1780. doi: 10.1111/ans.17699. Epub 2022 May 3.
7
Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy.微创手术与手术量特定的生存率及围手术期结局:妇科恶性肿瘤领域证据的未满足需求
J Clin Med. 2021 Oct 19;10(20):4787. doi: 10.3390/jcm10204787.
8
Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study.外阴癌治疗中医院规模与治疗结果的关系:日本妇科肿瘤学组的一项研究。
J Gynecol Oncol. 2021 Mar;32(2):e24. doi: 10.3802/jgo.2021.32.e24. Epub 2021 Jan 13.
9
Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period.早期宫颈癌的微创根治性子宫切除术:早期经验期的量效关系。
Gynecol Oncol. 2020 Aug;158(2):390-396. doi: 10.1016/j.ygyno.2020.05.009. Epub 2020 May 27.
10
Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes.早期卵巢癌的微创手术:医院手术量与短期围手术期结局的关联。
Gynecol Oncol. 2020 Jul;158(1):59-65. doi: 10.1016/j.ygyno.2020.04.045. Epub 2020 May 10.

本文引用的文献

1
Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer.根治性子宫切除术手术量与早期宫颈癌生存的关系。
Obstet Gynecol. 2019 Jun;133(6):1086-1098. doi: 10.1097/AOG.0000000000003280.
2
Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer.年轻低危型子宫内膜癌患者行卵巢保留的利用模式和结局。
Gynecol Oncol. 2019 Jul;154(1):45-52. doi: 10.1016/j.ygyno.2019.04.653. Epub 2019 Apr 26.
3
Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.盆腔廓清术治疗妇科恶性肿瘤的疗效和结局:一项基于人群的研究。
Gynecol Oncol. 2019 May;153(2):368-375. doi: 10.1016/j.ygyno.2019.02.002. Epub 2019 Feb 19.
4
Institutional volume affects long-term survival following lung transplantation in the USA.在美国,机构手术量影响肺移植后的长期生存率。
Eur J Cardiothorac Surg. 2019 Feb 2. doi: 10.1093/ejcts/ezz014.
5
Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.预测女性接受妇科恶性肿瘤盆腔廓清术的短期手术并发症。
Gynecol Oncol. 2019 Jan;152(1):151-156. doi: 10.1016/j.ygyno.2018.10.036. Epub 2018 Nov 8.
6
Effect of Institutional Case Volume on In-hospital Mortality After Living Donor Liver Transplantation: Analysis of 7073 Cases Between 2007 and 2016 in Korea.机构病例量对活体肝移植术后院内死亡率的影响:2007 年至 2016 年韩国 7073 例病例分析。
Transplantation. 2019 May;103(5):952-958. doi: 10.1097/TP.0000000000002394.
7
The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.外科医生手术量对妇科癌症盆腔廓清术后结局的影响。
J Gynecol Oncol. 2018 Sep;29(5):e68. doi: 10.3802/jgo.2018.29.e68. Epub 2018 May 4.
8
Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer.随着时间的推移,接受子宫内膜癌子宫切除术的女性的手术量和结局变化。
Obstet Gynecol. 2018 Jul;132(1):59-69. doi: 10.1097/AOG.0000000000002691.
9
National trends in total pelvic exenteration for gynecologic malignancies.妇科恶性肿瘤全盆腔脏器切除术的全国趋势。
Am J Obstet Gynecol. 2016 Sep;215(3):395-6. doi: 10.1016/j.ajog.2016.06.031. Epub 2016 Jul 12.
10
Center Volume Is Associated With Outcome After Pancreas Transplantation Within the Eurotransplant Region.在欧洲移植区域内,胰腺移植后的中心移植量与预后相关。
Transplantation. 2017 Jun;101(6):1247-1253. doi: 10.1097/TP.0000000000001308.

妇科恶性肿瘤盆腔脏器清除术的医院手术量与围手术期死亡率

Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies.

作者信息

Matsuo Koji, Matsuzaki Shinya, Mandelbaum Rachel S, Matsushima Kazuhide, Klar Maximilian, Grubbs Brendan H, Roman Lynda D, Wright Jason D

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California.

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

出版信息

J Surg Oncol. 2020 Feb;121(2):402-409. doi: 10.1002/jso.25770. Epub 2019 Nov 19.

DOI:10.1002/jso.25770
PMID:31746006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523231/
Abstract

BACKGROUND AND OBJECTIVES

To examine the association between hospital surgical volume and perioperative mortality of pelvic exenteration performed for gynecologic malignancies.

METHODS

A population-based retrospective study utilizing the Nationwide Inpatient Sample was conducted to examine pelvic exenteration for gynecologic malignancies from 2001 to 2011. Annualized hospital surgical volume was defined as the average number of procedures a hospital performed per year in which at least one case was performed, and this was correlated to perioperative mortality.

RESULTS

A total 1912 exenterations performed at 181 centers were included. Nearly two thirds of exenteration-performing centers had a minimum surgical volume of one case per year (121 centers, 66.9%). Perioperative mortality rate was 1.8%. In multivariable analysis surgical volume remained an independent factor for perioperative mortality (adjusted-odds ratio 0.21; 95% confidence interval, 0.09-0.49; P < .001). Perioperative mortality rates were 3.7% for the centers with minimum surgical volume (1 exenteration a year), 1.4% for the centers performing more than one but two or less exenterations a year, and 0% for the top decile centers (>2 exenterations a year), respectively (P < .001).

CONCLUSION

Pelvic exenteration for gynecologic malignancy is a rare surgical procedure with most hospitals performing few cases annually. A higher surgical volume of pelvic exenteration was associated with lower perioperative mortality.

摘要

背景与目的

探讨妇科恶性肿瘤盆腔廓清术的医院手术量与围手术期死亡率之间的关联。

方法

利用全国住院患者样本进行一项基于人群的回顾性研究,以考察2001年至2011年期间妇科恶性肿瘤盆腔廓清术的情况。年度医院手术量定义为一家医院每年至少实施一例手术的平均手术例数,并将其与围手术期死亡率相关联。

结果

纳入了在181个中心实施的总共1912例廓清术。近三分之二实施廓清术的中心每年的最低手术量为1例(121个中心,66.9%)。围手术期死亡率为1.8%。在多变量分析中,手术量仍然是围手术期死亡率的一个独立因素(调整比值比为0.21;95%置信区间为0.09 - 0.49;P < 0.001)。每年最低手术量(每年1例廓清术)的中心围手术期死亡率为3.7%,每年实施超过1例但2例或更少廓清术的中心为1.4%,而手术量排名前十分之一的中心(每年>2例廓清术)为0%(P < 0.001)。

结论

妇科恶性肿瘤盆腔廓清术是一种罕见的外科手术,大多数医院每年实施的病例数很少。盆腔廓清术的手术量越高,围手术期死亡率越低。